Design For R&D Project Of HBIG-Ⅳ Of SY Company

Under the serious situation of more and more competitive market of blood products home and abroad, in order to reach a target of company strategy - 'most extractive and strongest' and firm the leading position in the domestic market of drugs for preventing Hepatitis B re-infection of Hepatitis B relating liver transplant, SY Company take a method of prolong the already have production line in new product' s R&D, according to the company' s own organization ability. And HBIG-IV is the right new project prolonging from the already have production line of immunoglobulins.Penman as one of the responsible persons participate the whole R&D process, and is in charge of the design of R&D project as well as laboratory research of the product.This Design analyzes the market chance of HBIG-IV in detail. The product is clinical urgent required product with high commercial and social value, and also is a strong weapon to establish famous brand.Because the item product is a new drug in domestic market though it has already launched in market abroad, its R&D must pass through small trials, middle trials, pre-clinical trials for animals, clinical trials and processes of submitting several times. With long time and cost, the R&D process needs inner and outer...